Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gerrit Hamre"'
Autor:
Amy Corneli, PhD, MPH, Christine Pierre, RN, Terri Hinkley, RN, BScN, MBA, CCRC, Li Lin, MS, Christopher B. Fordyce, MD, MSc, Gerrit Hamre, MA, Matthew T. Roe, MD, MHS
Publikováno v:
Contemporary Clinical Trials Communications, Vol 6, Iss C, Pp 31-38 (2017)
Concerns have been raised over the high turnover rate for clinical investigators. Using the U.S. Food and Drug Administration's (FDA) Bioresearch Monitoring Information System database, we conducted an online survey to identify factors that affect pr
Externí odkaz:
https://doaj.org/article/2b72abf138d94bdfaf24fb33bb80b090
Autor:
Christopher B. Fordyce, Matthew T. Roe, Christine Pierre, Terri Hinkley, Gerrit Hamre, Pamela Tenaerts, Jonathan McCall, James D. Topping
Publikováno v:
Contemporary Clinical Trials Communications, Vol 15, Iss , Pp - (2019)
Background: High turnover rates among clinical trial investigators contribute to inefficiency, instability, and increased costs for the clinical research enterprise; however, factors contributing to investigator turnover have not been well characteri
Externí odkaz:
https://doaj.org/article/99f25152f02f496bace61aa0aced455e
Autor:
Terri Hinkley, Gerrit Hamre, Christopher B. Fordyce, Li Lin, Matthew T. Roe, Christine Pierre, Amy Corneli
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 6, Iss C, Pp 31-38 (2017)
Contemporary Clinical Trials Communications, Vol 6, Iss C, Pp 31-38 (2017)
Concerns have been raised over the high turnover rate for clinical investigators. Using the U.S. Food and Drug Administration's (FDA) Bioresearch Monitoring Information System database, we conducted an online survey to identify factors that affect pr
Autor:
Jan Hewett, Annemarie Forrest, Gerrit Hamre, David Babaian, Penny Randall, Vaishali Popat, Maria Apostolaros, Laura Podolsky, Amy Corneli
Publikováno v:
Therapeutic Innovation & Regulatory Science
Background Traditional clinical trials are often expensive, inefficient, include selected populations, and can create significant participant burden via travel and other logistical demands. Using new technologies and methodologies to promote a decent
Autor:
Amy Corneli, Sara B. Calvert, Jennifer C. Goldsack, Zachary P Hallinan, Gerrit Hamre, Brian Perry, Annemarie Forrest
Publikováno v:
Clinical trials (London, England). 15(1_suppl)
The mission of the Clinical Trials Transformation Initiative, a public–private partnership co-founded by the U.S. Food and Drug Administration and Duke University, is to develop and drive adoption of practices that will increase the quality and eff